Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Thrombolysis (rt-PA + Tenecteplase) in Proximal MCA Occlusion
NCT02338466Phase 2Withdrawn
- Sponsor
- CHU de Martinique
- Start
- Jul 2016
- Primary completion
- Jul 2018
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
Phase 2, randomised, single-blind trial of tenecteplase in ischemic stroke (2 arms), sponsored by CHU de Martinique. Primary endpoint: modified Rankin Scale at 3 months. Planned start Jul 2016; status: withdrawn.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02338466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338466.